- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05264857
Decision Aid and Thyroid Nodules Management
April 19, 2023 updated by: Lukasz Czerwonka, Stony Brook University
Decision Aid for Management of Thyroid Nodules and Early Thyroid Cancer
Patients with small favorable malignant or indeterminate thyroid nodules will receive information about management of thyroid nodules.
Participants will be asked to complete brief surveys at the time of enrollment, shortly after the consultation appointment with the surgeon, and a few months after either the consultation or the surgery, to assess their satisfaction with their decision and decision making process.
All participants will receive routine care and counseling by their endocrinologist and surgeon.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
134
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Carla Flores
- Phone Number: 631-444-9044
- Email: Carla.GomezjuradoFlores@stonybrookmedicine.edu
Study Contact Backup
- Name: Caterina Vacchi-Suzzi
- Phone Number: 631-216-2993
- Email: caterina.vacchi-suzzi@stonybrookmedicine.edu
Study Locations
-
-
New York
-
Stony Brook, New York, United States, 11794
- Recruiting
- Stony Brook University Cancer Center
-
Contact:
- Carla Flores
- Phone Number: 631-444-9044
- Email: Carla.GomezjuradoFlores@stonybrookmedicine.edu
-
Contact:
- Caterina Vacchi-Suzzi
- Phone Number: 6312162993
- Email: caterina.vacchi-suzzi@stonybrookmedicine.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Histology showing indeterminate or malignant thyroid pathology (Bethesda III-VI)
- Thyroid nodule size less or equal to 2cm
Exclusion Criteria:
- History of thyroid surgery
- History of thyroid cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Thyroid nodule information
|
Participants will receive information about thyroid nodules and their management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of congruence between informed values and treatment choice
Time Frame: 6 months from surgery or surgical consultation date
|
Percent of patients with congruence between treatment option and informed values based on a survey
|
6 months from surgery or surgical consultation date
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lukasz Czerwonka, MD, Lukasz.Czerwonka@stonybrookmedicine.edu
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2022
Primary Completion (Anticipated)
September 30, 2026
Study Completion (Anticipated)
September 30, 2026
Study Registration Dates
First Submitted
February 17, 2022
First Submitted That Met QC Criteria
March 1, 2022
First Posted (Actual)
March 3, 2022
Study Record Updates
Last Update Posted (Actual)
April 20, 2023
Last Update Submitted That Met QC Criteria
April 19, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBU-DECISION-AID-THYROID
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Nodule
-
Tseung Kwan O Hospital, Hong KongNot yet recruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid Nodule
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University... and other collaboratorsRecruitingRadiofrequency Ablation | Thyroid Nodule, Toxic or With Hyperthyroidism | Autonomous Thyroid Function | Thyroid Nodule; Hyperthyroidism | Iodine Hyperthyroidism | Iodine Adverse ReactionNetherlands
-
Aarhus University HospitalOdense University Hospital; University of AarhusEnrolling by invitationThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
Pulse Biosciences, Inc.RecruitingThyroid Nodule (Benign)Italy
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); University of MichiganCompletedThyroid Cancer | Thyroid Nodule | Benign Thyroid NoduleUnited States
-
University of Sao Paulo General HospitalRecruiting
-
Assiut UniversityNot yet recruitingThyroid Nodule (Benign)
-
Fundatia Bio-ForumCompletedBenign Thyroid NoduleRomania
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnThyroid Gland NoduleUnited States
Clinical Trials on Thyroid Nodule Management Education
-
Gloucestershire Hospitals NHS Foundation TrustNot yet recruiting
-
DiaxonhitUnknownThyroid Cancer | Thyroid NoduleFrance
-
Bezmialem Vakif UniversityUnknown
-
BioTex, Inc.Rhode Island HospitalCompletedThyroid Neoplasms | Nodular Goiter | Thyroid Cancer | Thyroid NoduleUnited States
-
University of TorontoMount Sinai Hospital, New YorkCompleted
-
University of TorontoUnity Health TorontoUnknown
-
Lawson Health Research InstituteGlaxoSmithKline; PfizerCompleted
-
Taipei Medical UniversityMinistry of Science and Technology, TaiwanRecruiting
-
University of Sao PauloCompletedChronic Low Back PainBrazil
-
Okan UniversityCompleted